hVIVO plc 2018 Annual Report and Financial Statements (2431X)
April 26 2019 - 3:56AM
UK Regulatory
TIDMHVO
RNS Number : 2431X
hVIVO plc
26 April 2019
hVIVO plc
("hVIVO" or the "Company")
2018 Annual Report and Financial Statements and Annual General
Meeting 2019
London, UK - 26 April 2019: hVIVO plc (AIM: HVO), announces that
the following documents have been sent to shareholders.
-- Annual Report and Financial Statements for the year ended 31 December 2018
-- Notice of Annual General Meeting ("AGM") 2019
-- Form of Proxy for the AGM
In accordance with AIM Rule 26, these documents are available on
Company's website at,
http://hvivo.com/investors/financial-reports/.
The AGM is scheduled to be held at 10.00am BST on Thursday 30
May 2019 on 3(rd) Floor, Queen Mary BioEnterprises Innovation
Centre, 42 New Road, London, E1 2AX.
For further information please contact:
hVIVO plc
Trevor Phillips (Executive Chairman) +44 207 756 1300
Shelley Fraser (Finance Director & Company Secretary)
Fleur Wood (EVP, Investor Relations & Communications)
Numis Securities Limited +44 207 260 1000
Freddie Barnfield / Huw Jeremy (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
FTI Consulting
Simon Conway / Victoria Foster Mitchell +44 203 727 1000
Notes to Editors:
hVIVO plc ("hVIVO") is pioneering a human-based clinical trial
platform to accelerate drug and vaccine development in respiratory
and infectious diseases. Leveraging human disease models in flu,
RSV, HRV and respiratory indications, the hVIVO platform captures
disease in motion, illuminating the entire disease life cycle from
healthy to sick and back to health. Based in the UK, market leader
hVIVO has conducted more than 50 clinical studies and inoculated
over 2700 volunteers.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ACSSELSAMFUSEIL
(END) Dow Jones Newswires
April 26, 2019 04:56 ET (08:56 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024